Intellectual property

Digital

AI as an inventor: Defining ownership in the pharma sector

The global pharmaceutical industry is witnessing a surge in innovation, with the industry experiencing a 5% growth in the number of AI-related patent applications in Q1 2024 and

News

Bill that would cut down ‘patent thickets’ clears Senate

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.

News

Senate Majority Whip and Senate Judiciary Committee chair Dick Durbin (D-IL)

US senators accuse pharma firms of abusing patent system

Lawmakers across the political divide have accused the pharma industry of abusing the patent system to keep the prices of their products as high as possible in a combative

Digital

navigating intellectual property challenges

Risk management strategies to navigate IP challenges associa...

Artificial intelligence (AI) is revolutionising industries. But with this exciting new frontier comes a complex challenge: protecting your intellectual property (IP).

News

Biogen bonus as generic Tecfidera approvals are pulled in EU

The European Commission has pulled marketing authorisations for generic versions of Biogen’s oral multiple sclerosis therapy Tecfidera, after concluding that the brand qua

R&D